These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18323857)

  • 1. NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL.
    Russell RC; Ohh M
    EMBO Rep; 2008 May; 9(5):486-91. PubMed ID: 18323857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.
    Bonicalzi ME; Groulx I; de Paulsen N ; Lee S
    J Biol Chem; 2001 Jan; 276(2):1407-16. PubMed ID: 11024059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex.
    Sufan RI; Ohh M
    Neoplasia; 2006 Nov; 8(11):956-63. PubMed ID: 17132228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase.
    Heir P; Sufan RI; Greer SN; Poon BP; Lee JE; Ohh M
    Mol Cell Biol; 2013 Apr; 33(8):1621-31. PubMed ID: 23401859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.
    Stickle NH; Chung J; Klco JM; Hill RP; Kaelin WG; Ohh M
    Mol Cell Biol; 2004 Apr; 24(8):3251-61. PubMed ID: 15060148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.
    Hansen WJ; Ohh M; Moslehi J; Kondo K; Kaelin WG; Welch WJ
    Mol Cell Biol; 2002 Mar; 22(6):1947-60. PubMed ID: 11865071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Elongin C and Skp1 sequences that determine Cullin selection.
    Yan Q; Kamura T; Cai Y; Jin J; Ivan M; Mushegian A; Conaway RC; Conaway JW
    J Biol Chem; 2004 Oct; 279(41):43019-26. PubMed ID: 15280393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The von Hippel-Lindau tumor suppressor gene product promotes, but is not essential for, NEDD8 conjugation to cullin-2.
    Wada H; Yeh ET; Kamitani T
    J Biol Chem; 1999 Dec; 274(50):36025-9. PubMed ID: 10585493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
    Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex.
    Yun J; Kim YI; Tomida A; Choi CH
    Biochem Biophys Res Commun; 2009 Nov; 389(1):5-9. PubMed ID: 19695223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation of the ubiquitin-like protein NEDD8 to cullin-2 is linked to von Hippel-Lindau tumor suppressor function.
    Liakopoulos D; Büsgen T; Brychzy A; Jentsch S; Pause A
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5510-5. PubMed ID: 10318914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
    Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
    Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.
    Clifford SC; Cockman ME; Smallwood AC; Mole DR; Woodward ER; Maxwell PH; Ratcliffe PJ; Maher ER
    Hum Mol Genet; 2001 May; 10(10):1029-38. PubMed ID: 11331613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex.
    Cardote TAF; Gadd MS; Ciulli A
    Structure; 2017 Jun; 25(6):901-911.e3. PubMed ID: 28591624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.
    Cai QL; Knight JS; Verma SC; Zald P; Robertson ES
    PLoS Pathog; 2006 Oct; 2(10):e116. PubMed ID: 17069461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS.
    Uchida T; Tamaki Y; Ayaki T; Shodai A; Kaji S; Morimura T; Banno Y; Nishitsuji K; Sakashita N; Maki T; Yamashita H; Ito H; Takahashi R; Urushitani M
    Sci Rep; 2016 Jan; 6():19118. PubMed ID: 26751167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The COP9/signalosome increases the efficiency of von Hippel-Lindau protein ubiquitin ligase-mediated hypoxia-inducible factor-alpha ubiquitination.
    Miyauchi Y; Kato M; Tokunaga F; Iwai K
    J Biol Chem; 2008 Jun; 283(24):16622-31. PubMed ID: 18424433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
    He Z; Liu S; Guo M; Mao J; Hughson MD
    Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic dissection of the von Hippel-Lindau (VHL) interactome.
    Lai Y; Song M; Hakala K; Weintraub ST; Shiio Y
    J Proteome Res; 2011 Nov; 10(11):5175-82. PubMed ID: 21942715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.